BIO 2026: Orbis Medicines is developing 'next generation macrocycles' and believes that with a couple of products new to the market, this is the next class of medicines that will take off

Media Coverage

Jun 22

Written by Jamison Wright

https://www.biotechtv.com/post/orbis-medicines-june-22-2026

Podcast

Jamison Wright https://jamisonwright.com

Orbis Medicines Enters Multi-Target Drug Discovery Partnership with Novo Nordisk Worth up to USD 1.4 Billion

Macrocycles: big is the new beautiful